Research & Economic Development

Office of the Vice Chancellor


IBC approval of recombinant or synthetic nucleic acid molecules and biohazardous research protocols is effective for three years. PIs must complete an IBC Annual Renewal each year to continue work for up to three years after the initial approval. After three years, the application must be resubmitted and reviewed by the committee.

What needs IBC approval?

  • Recombinant or synthetic nucleic acid molecules
  • Hazardous biological agents (virus, bacteria, fungi, parasite, prion, rickettsia etc.)
  • Other potentially infectious materials (human or non-human primate blood, serum, plasma, body fluids, unfixed tissue, organ and cells)
  • Biological toxins including select agent toxins
  • Inactivated Biological Samples derived from BSL-3 or BSL-4 agents
  • Attenuated pathogens derived from BSL-3 or BSL-4 agents
  • Human gene transfer
  • Transgenic animals or plants
IBC Application
IBC Application A1- Recombinant DNA (rDNA) Registration Form
IBC Application A2 - Registration of BioSafety Level 2 (BSL-2) and Biosafety Level 3 (BSL-3)
     Infections Agents, Select Agents, and Biological Toxins
IBC Application A3 - BSL-3 Containment Measures
IBC Application A4 - Registration of Blood Borne Pathogens and Other Potentially Infectious Material (OPIM)

See NIH Guidelines for additional information.

Contact the IBC

IBC Compliance Office
816 235-5929

IBC Chair - Jakob Waterborg, PhD
816 235-2591

UMKC Biological Safety Officer (BSO) - Tim Sturgis, RBP
816 235-1844


Recent NewsView all